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Abstract 
Background: The WHO recommends the inclusion of rubella testing in the measles surveillance system. 
Laboratory diagnosis of measles and rubella virus infection is achieved by serological assay for specific IgM 
from a sample of blood drawn by vein puncture. This conventional method of sample collection is invasive and 
less acceptable.   
Aim: To assess feasibility of using oral fluid as an alternative method in the detection of rubella-virus specific 
IgM in routine surveillance of rubella 
Settings and Design: A prospective laboratory-based cross-sectional study using matched oral fluid and serum 
collected from emerging outbreaks of rash-like illnesses across Kenya.  
Methods and Material: Matching samples of 176 patients were investigated for IgM specific antibodies using 
enzyme linked immunosorbent assays.  
Statistical analysis used: The kappa (k) statistic was used to measure inter-observer variations.  
Results: The prevalence of rubella using serum and oral methods was 26.7% and 23.3% respectively. Sensitivity 
and specificity for rubella IgM in oral fluid when tested against the gold standard was 86% and 93% 
respectively.  Kappa statistic value was 0.80 suggesting substantial agreement between the two methods.  
Conclusion: The study showed that oral fluid method is a promising simple alternative, non-invasive and more 
acceptable specimen of choice for rubella diagnosis. The alternative method will be more applicable to disease 
surveillance programmes where clinical settings are varied. The advantage of this method of sample collection is 
ease and safety with minimum requirement for shipment to laboratory. These findings will support the entire 
disease surveillance system in Kenya and also can have extended use in conducting epidemiological studies.  
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1. Introduction 
Since inception of measles surveillance in Kenya, the assay method of choice has been using blood for IgM 
detection using a commercially manufactured ELISA kit.  As a standard procedure, rubella testing is also 
performed using the same sample. This is because rubella infection presents with almost similar clinical 
manifestations as measles. 
The WHO recommended rubella testing as a differential diagnosis of measles in routine measles surveillance 
system of member countries. In support of the initiative, it established a global measles and rubella laboratory 
network [23]. Data collected over the years showed that rubella is endemic in Kenya and 30% to 50% of 
suspected measles cases are laboratory confirmed as being caused by rubella virus [23]. This has led to 
introduction of Measles and Rubella (MR) Vaccine into the National Immunization schedule. 
Rubella virus is a teratogenic virus that causes congenital disorders to the children who are born to mothers who 
had the infection during the first trimester of their pregnancy [4]. Rubella virus affects children, adolescents and 
the young adults. Around 50% of the rubella infections are subclinical and can only be confirmed through 
laboratory testing. It may be asymptomatic or mild infection in adults and children [3]. This infection during 
pregnancy especially during the first trimester can result in miscarriage, stillbirth to congenital defect if the 
foetus is not miscarried [22]. The main symptoms include inflammation of the lymph nodes and a maculopapular 
rash that may be preceded by mild catarrhal symptoms. Lyphadenopathy occurs from 5-7 days before the onset 
of the rash and up to 2 days after [5]. Rubella virus infection occurs via the respiratory route. It infects the 
nasopharynx and multiplies in the lining of the respiratory tract and in local lymph nodes before getting to 
viraemic phase that begins within 4-5 days after the infection and spreads to the rest of the body. Rubella virus 
has an incubation period of 14-18 days [14]. 
In patients where phlebotomy is not possible, saliva can be collected for salivary rubella-specific IgA testing. 
Positive contact with other patients known to have rubella adds strong epidemiological evidence to the diagnosis. 
The contact with any infected person in any way, including semen through sex, saliva, or mucus, can cause 
infection [19].  
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In this study oral fluid was used as an alternative method for detection of rubella IgM. This method was explored 
because of the challenges posed by collection, maintenance and safety of blood sample. In addition published 
literature has shown that transportation of oral fluid does not require low temperatures during shipment when 
compared to blood [17].  
 
2. Materials and methods 
Ethical consideration 
Ethical clearance was sought from Ethical Review Committee and also from Jomo Kenyatta University of 
Agriculture and Technology. Authority was also sought from the Ministry of Health since the samples were 
collected as part of routine surveillance of measles and rubella. The research was conducted in accordance with 
KEMRI guidelines on human sample use and care and the internationally accepted principles for laboratory 
procedures using standard operating procedures [26].  
Study site and design  
The study site was determined by outbreaks of rash-like illness in the country. On notification of emerging rash-
like outbreaks, samples were collected using an established disease surveillance system. The samples were 
collected from different districts in Kenya and transported to the Kenya Medical Research Institute (KEMRI) 
laboratory for processing. The districts were; Fafi, Garissa, Kaloleni, Kamukunji, Lagdera, Nairobi North, 
Nairobi West, Nakuru North, Tana River, Taveta, Turkana North, Wajir East, Wajir South, Wajir West and 
Kakuma (Sudanese living in Kenya).This was a prospective laboratory-based cross-sectional study design over a 
period of six months from June- December 2010.  
Study population 
Samples were collected using the WHO standard [25] case definition for based on the clinical presentation under 
routine surveillance system.   
Sample size  
A hundred and eighty (180) matched samples were collected based on the Ministry of Health (MoH) surveillance 
system 2008-2009 requirement for laboratory confirmation of suspected measles outbreaks.  
Specimens collection 
Samples of oral fluid and blood were collected from each study participant within 28 days of rash onset. Venous 
blood (3mm) was collected in a vacutainer tube technique described by WHO [25]. Whole blood specimen was 
allowed to fully clot for 15-30 minutes at room temperature before harvesting of serum. Serum was transported 
using cool boxes with frozen ice packs and stored at 4oC waiting in the laboratory until analysis.  The period of 
storage within the laboratory was less than 3 days.  
Oral fluid was collected using an ORACOL test kit (Malvern Medical Developments, Worcester, UK). The 
device has a sterile swab, with an absorbent material that was placed into the patient’s mouth between the lower 
cheek and gum and left in until adequately moistened. The pad was removed and inserted in the bottom of a vial 
containing preservative. Consistency in labelling for the two samples from a patient was ensured. The same 
identification number was entered in the case-based request form.  The oral fluid in the swabs was extracted as 
soon as it arrived in the laboratory by adding 1ml of the virus transport medium to the tube containing the oral 
fluid swab. The swab was then agitated by vortexing to ensure foaming of the transport medium. The swab was 
removed from the tube by a twisting motion; centrifugation at 2000 rpm for 5 minutes to ensure that much liquid 
was recovered from the swab. Extracted fluid was stored at 4oC until analysis was done.  
 
Diagnosis of Rubella Virus IgM using Serum method  
The Enzygnost®Anti-Rubella-Virus/IgM immunoassay (Siemens Healthcare Diagnostics Products, Marburg, 
Germany) was used to analyse the serum specimens to detect Rubella-Virus IgM. Enzyme Immunoassay is for 
both qualitative and quantitative determination of IgM antibodies to rubella virus in human serum and plasma. 
The test was developed for testing individual samples, not for pooled samples. The method is ELISA-based and 
uses a commercially available kit therefore manufacturer instructions were used. Results were interpreted 
qualitatively using optical densities (OD). The reading of optical density was done at 450/650 nm using 
spectrophotometric plate reader. 
 
Diagnosis of Rubella Virus IgM using Oral fluid method. 
The Microimmune Rubella IgM capture Enzyme Immunoassay kit (Microimmune Ltd, Middlesex, UK) was 
used to detect Rubella IgM in oral fluid. Samples and test reagents were brought to room temperature (18-24 oC) 
prior to testing. Manufacturer instructions were followed in the testing using the kit. The reading of optical 
density was done at 450/650 nm using spectrophotometric plate reader. 
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Oral fluid diagnostic test interpretation Data analysis and presentation 
In each test, the relative sensitivity, specificity, positive predictive value (PPV) and negative predictive value 
(NPV) of oral-fluid results were calculated relative to serum being the gold standard. Concordance between the 
oral fluid-based and corresponding serum-based assay results was evaluated by considering all sample pairs in 
the study.  
Descriptive findings were presented in form of tables, graphs and charts to show the comparison of the results. 
The kappa (k) statistic was used to measure inter-observer variability.  
Results 
Rubella seropositivity using serum and oral fluid were 26.7% and 23.3% respectively (Table 1) Samples took 
an average of three days to arrive in the laboratory. 
Table 1: Comparison of oral fluid and serum prevalence  
Out come  Rubella  
   Serum  Oral fluid  
Positive  47(26.7)  41(23.3)  
Negative  113 (64.2)  117 (66.5)  
 Rubella seropositivity using serum and oral fluid were 26.7% and 23.3% respectively. 
 Samples took an average of three days to arrive in the laboratory  
Sensitivity and specificty for rubella 
Serum test for rubella showed that 64.2% of the participants tested negative while 26.7% tested positive. Oral 
fluid on the other hand revealed that 63.8% tested negative while 36.2% tested positive. 
In the rubella test, concordance was confirmed in 176 of samples resulting in sensitivity rate of 86%.and 
specificity rate of 93% 
Table 2: Sensitivity and specificity for Rubella virus  
Rubella 
test  
Sample size  Sensitivity 
(%)  
95% CI  Specificty  
(%)   
95% CI  NPV  PPV  
Serum  176                    
Oral fluid  176  86  0.05  93  0.05  93  86  
 Serum test for rubella showed that 64.2% of the participants tested negative while 26.7% tested positive.  
 Oral fluid on the other hand revealed that 63.8% tested negative while 36.2% tested positive.  
 In the rubella test, concordance was confirmed in 176 of samples resulting in sensitivity rate of 86%.and 
specificity rate of 93%  
Rubella test 
The calculation based on the difference between how much agreements were actually present (“observed” 
agreement) compared to how much agreement would be expected to be present by chance alone (“expected” 
agreement). The statistical analysis was necessary to determine whether the oral fluid assays were effective in 
detecting the ribonucleic acid paramyxovirus in the same manner as invasive serum assays. Since the hypothesis 
of this study was to examine whether Rubella oral fluid IgM assays can be used as an alternative to Rubella 
serum IgM assays, the study checked the relationship between the two tests using this tool, the calculation based 
on the difference between how much agreements were actually present (“observed” agreement) compared to 
how much agreement would be expected to be present by chance alone (“expected” agreement) is determined. 
Calculations based on results for rubella tests are 0.56 
Therefore, observed agreement is simply the percentage of all tests for which the two test evaluations agree, 0.91 
Kappa, K is 0.80. 
Discussion 
The findings in this study confirmed that an oral fluid sample can be used as an alternative to blood in the 
surveillance of rubella in Kenya. This proposed and tested method will be useful especially post introduction of 
measles and rubella (MR) vaccination in Kenya (ref). As a follow of the introduction of MR vaccine in routine 
immunization, active surveillance of rubella cases in assessing the impact of the intervention and also 
serosurveys will benefit greatly from these results. The samples used were collected from geographically diverse 
regions in Kenya confirming versatility of the new method. Failure to perform laboratory confirmation of 
suspected outbreaks can lead to missed opportunities to prevent transmission. Laboratory confirmation has 
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become important to both measles and rubella control programs world over [7]. Existing laboratory methods rely 
largely on the detection of significant rises in rubella antibody titer or the detection of rubella IgM antibody. 
Collection of blood sample is often considered invasive requiring specially trained persons which can limit 
usability. A non-invasive method of sample collection can have an important role especially in areas with limited 
resources[12]. 
The findings in this study demonstrated high level of concordance between serum and oral fluid IgM results 
which was demonstrated by the high specificity and sensitivity rates and an acceptable agreement using Kappa 
statistic. Other investigators have also confirmed versatility of oral fluid for rubella IgM detection. The results of 
Talat et al., yr?[24] showed indeed that whole saliva contains IgM antibody at concentrations high enough to be 
diagnostically useful. Its applicability has been tested widely as demonstrated by Author? Where antibody-
capture radio immunoassay, showed that virus specific IgM was detected in 100% of rubella saliva samples 
collected between 1 and 5 weeks after onset of disease [21]. Also in another community-based study in England 
and Wales found out that the sensitivity of saliva rubella IgM testing was 81% when compared to blood.  
Another study done in Ethiopia by Nokes et al.,[15] showed that the overall sensitivity and specificity were 79% 
and 90% for rubella in a study done in Ethiopia.. The, timing of salivary specimen collection is another 
important factor in determining whether viral specific IgM will be detected. Although this study did not focus on 
duration after rash onset for sample collection several studies have confirmed that rubella IgM can be detected 
well shortly after rash onset but within 14 days of rash onset [7]  
The mildness of the majority of rubella cases makes parents and medical practitioners reluctant to take blood for 
diagnosis. Moreover, in developing countries rubella outbreaks can occur with no clinical recognition, even in a 
community in which health is being monitored. The use of non-invasive specimens for diagnosis offers several 
advantages over blood such as: acceptability to patients, applicability to children and reuse of disposable 
equipment can be ruled out. In addition occupational risk from needle stick injures is eliminated. The present 
work and other studies indicate that oral fluid is a viable alternative to serum for monitoring the impact of 
vaccination programmes and disease surveillances in the future.  
 
Data has shown that approximately 30 to 50% of suspected measles cases are often confirmed as being caused 
by rubella virus (, [23]. Diagnosis of rubella using oral fluid samples instead of serum samples offers many 
advantages that can support disease surveillance programmes in any country [12]. Among the many advantages 
are ease of specimen collection, non-invasiveness and also comparative acceptability in many communities. .  
The results demonstrated that oral fluid specimens are a convenient alternative to serum for diagnosis of recent 
rubella infection. The widespread acceptability of oral fluid collection should facilitate the investigation of 
rubella outbreaks and have an important role in controlling the disease in regional and national public health 
laboratories worldwide. Additionally, refusal in collecting blood samples due to cultural or religious traditions 
and vein puncture related problems may increase the difficulty in obtaining specimens for testing [8]. 
Oral fluid is a valid alternative to serum for IgM detection of rubella antibodies that could play a major role in 
surveillance of rubella and also for use in rubella serosurveys.  This study therefore confirms the potential of 
incorporating enzyme linked immunosorbent assay using oral fluid as a sample of choice in detection of rubella 
IgM. For routine surveillance and epidemiological surveys nationwide and also for other regions with similar 
settings. Moreover, the turnaround time for results in this method does not deviate from that of the gold standard 
yet it offers additional advantages comparatively. 
5. Conclusion 
The study showed that oral fluid method is a promising simple alternative, non-invasive and more acceptable 
specimen of choice for rubella diagnosis. The alternative method will be more applicable to disease surveillance 
programmes where clinical settings are varied. The advantage of this method of sample collection is ease and 
safety with minimum requirement for shipment to laboratory. These findings will support the entire disease 
surveillance system in Kenya and also can have extended use in conducting epidemiological studies.  
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